These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1539354)

  • 41. Pediatric renal transplantation: comparative study with renal transplantation in the adult population.
    Parada B; Figueiredo A; Nunes P; Bastos C; Macário F; Roseiro A; Dias V; Rolo F; Mota A
    Transplant Proc; 2005; 37(6):2771-4. PubMed ID: 16182806
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Renal transplant odyssey.
    Elli M; Baroni B; Boffo B; Tisone G; Pisani F; Valeri M; Utzeri G; De Paolis P; Manca di Villahermosa S; Famulari A
    Transplant Proc; 1992 Oct; 24(5):1853-4. PubMed ID: 1412881
    [No Abstract]   [Full Text] [Related]  

  • 43. Pathological differential diagnostics of proteinuria and late failure after renal transplantation.
    Castelao AM; Griñó JM; Serón D; Andrés E; GilVernet S; Bover J; Carrera M; Torras J; Alsina J
    Transplant Proc; 1992 Feb; 24(1):110-2. PubMed ID: 1539198
    [No Abstract]   [Full Text] [Related]  

  • 44. Renal xenograft rejection: prolonging effect of captopril, ACE-inhibitors, prostacyclin, and cobra venom factor.
    Kemp E; Steinbrüchel D; Starklint H; Larsen S; Henriksen I; Dieperink H
    Transplant Proc; 1987 Dec; 19(6):4471-4. PubMed ID: 2827356
    [No Abstract]   [Full Text] [Related]  

  • 45. [Transplanted kidney function in the late period].
    Belorusov OS; Goriaĭnov VA; Nevzorova TN
    Khirurgiia (Mosk); 1979 Aug; (8):57-61. PubMed ID: 388034
    [No Abstract]   [Full Text] [Related]  

  • 46. Renal transplantation.
    Suthanthiran M; Strom TB
    N Engl J Med; 1994 Aug; 331(6):365-76. PubMed ID: 7832839
    [No Abstract]   [Full Text] [Related]  

  • 47. Effects of angiotensin-converting-enzyme inhibitors on progression to end-stage renal failure in chronic vascular rejection.
    Rustom R; Paraoan MT; Sells RA; Jackson MJ; Hammad A; Bakran A; Brown M; Ahmad RA; Williams PS; Bell GM; Sharma A; Bone JM
    Transplant Proc; 2001; 33(1-2):1175-6. PubMed ID: 11267244
    [No Abstract]   [Full Text] [Related]  

  • 48. Angiotensin converting enzyme inhibition reduces proteinuria in Nigerians with chronic renal disease.
    Ajayi AA; Ajayi AT
    Eur J Clin Pharmacol; 1990; 39(4):423-4. PubMed ID: 2076731
    [No Abstract]   [Full Text] [Related]  

  • 49. Early pitfalls in renal transplantation.
    Ona ET
    Transplant Proc; 1992 Aug; 24(4):1280-2. PubMed ID: 1496563
    [No Abstract]   [Full Text] [Related]  

  • 50. Protecting single-kidney allografts from long-term functional deterioration.
    Remuzzi G; Perico N
    J Am Soc Nephrol; 1998 Jul; 9(7):1321-32. PubMed ID: 9644646
    [No Abstract]   [Full Text] [Related]  

  • 51. Hypertension in chronic renal disease.
    Kidney Int; 1982 Dec; 22(6):702-12. PubMed ID: 6761490
    [No Abstract]   [Full Text] [Related]  

  • 52. Tryptophan immunoadsorption strongly reduces proteinuria in recurrent nephrotic syndrome.
    Büssemaker E; Passauer J; Franz T; Gross P
    Nephrol Dial Transplant; 2001 Jun; 16(6):1270-2. PubMed ID: 11390732
    [No Abstract]   [Full Text] [Related]  

  • 53. The pathophysiologic role of endothelin in acute vascular rejection after renal transplantation.
    Watschinger B; Vychytil A; Schuller M; Hartter E; Traindl O; Pohanka E; Ulrich W; Kovarik J
    Transplantation; 1991 Oct; 52(4):743-6. PubMed ID: 1926360
    [No Abstract]   [Full Text] [Related]  

  • 54. Recovery from "end-stage" renal disease.
    Quérin S
    Int J Artif Organs; 1996 May; 19(5):263-4. PubMed ID: 8791144
    [No Abstract]   [Full Text] [Related]  

  • 55. Pharmacological and dietary intervention in experimental models of chronic renal disease.
    Beukers JJ; Hoedemaeker PJ; Weening JJ
    Contrib Nephrol; 1988; 60():101-15. PubMed ID: 3278850
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of captopril, an angiotensin converting enzyme inhibitor, on the massive proteinuria due to chronic rejection after renal transplantation--a prospective study.
    Morales JM; Andres A; Montoyo C; Praga M; Alcazar JM; Algranati L; Rodicio JL
    Transplant Proc; 1992 Feb; 24(1):92-3. PubMed ID: 1539354
    [No Abstract]   [Full Text] [Related]  

  • 57. Angiotensin I-converting enzyme inhibition after renal transplantation.
    Grönhagen-Riska C; Fyhrquist F; Ahonen J; von Willebrand E; Häyry P
    Scand J Urol Nephrol Suppl; 1984; 79():63-7. PubMed ID: 6089320
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term follow-up study of renal transplant recipients.
    Hiraga S; Kitamura M; Kobayashi D; Hida M; Satoh T; Takeda M
    Transplant Proc; 1994 Aug; 26(4):2090-2. PubMed ID: 8066681
    [No Abstract]   [Full Text] [Related]  

  • 59. Low-dose angiotensin-converting-enzyme inhibitor captopril to reduce proteinuria in adult idiopathic membranous nephropathy: a prospective study of long-term treatment.
    Rostoker G; Ben Maadi A; Remy P; Lang P; Lagrue G; Weil B
    Nephrol Dial Transplant; 1995; 10(1):25-9. PubMed ID: 7724024
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.